Another recent publication related high SEMA3F expression in cancer tissue, specifically in BC tissue, to that in contiguous normal tissue, and the authors noted the possibility that SEMA3F may be associated with poor prognosis in patients with the HER2 + BC subtype [32]. The gene discussed is ERBB2; the disease is breast cancer.